Effect of Indoor Air Quality Improvement on Health in Patients With Interstitial Lung Disease
ConditionILD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorPeking Union Medical College
About this trial
Air pollution threatens the respiratory health of patients with interstitial lung disease (ILD). High-efficiency air purifiers, featuring easy operation and excellent particulate matter removal efficiency, have been shown in previous studies to potentially delay lung function deterioration and reduce acute exacerbation risk in respiratory disease patients. This randomized crossover study employs air purifiers to filter indoor gaseous pollutants, allergens, and other contaminants, aiming to alleviate respiratory irritation, improve daily life comfort, and enhance overall health status in ILD patients.
Eligibility criteria
Qualifiers
Patients diagnosed with interstitial lung disease (ILD).
Stable disease status, defined as no hospitalization due to acute exacerbation within the past month.
Disqualifiers
Patients with complications of severe organ failure (including heart, liver, or kidney failure), malignant tumors, or mental disorders.
A history of respiratory tract infection within the past two weeks.
Trial design
Treatments tested in this trial
- Air Purifier (with Filter) Arm
- Purifier (without Filter) Arm
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov